Protocol summary

Study aim
Achievement of combination treatment with higher efficacy and lower side effects than previous treatment methods of acne scars.
Design
Phase 3 controlled randomized double-blind clinical trial with parallel groups design of 10 patients. For randomization , Simple randomization by coin tossing was used.
Settings and conduct
Ten patients with acne scars were entered to study. In these patients, subcision technique was randomly performed on one side of the face and subcision technique plus SVF on the opposite side of the face. The degree of neoclagenosis was evaluated by ultrasound before and 3 months after intervention. Recovery rate was assessed using a patient-based mental scoring system and visual evaluation of scars.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Age range of 20-50 years; Moderate and severe scars; Conscious consent for participation in the study Exclusion criteria: Pregnancy and lactation; Malignancy
Intervention groups
Control: subcision technique on one side of the face Case: subcision technique plus SVF on the opposite side of the face
Main outcome variables
Scar size; Neoclagenosis; Patient mental scoring; Physician scoring

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20211121053126N1
Registration date: 2022-01-04, 1400/10/14
Registration timing: registered_while_recruiting

Last update: 2022-01-04, 1400/10/14
Update count: 0
Registration date
2022-01-04, 1400/10/14
Registrant information
Name
Azadeh Seifadini
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 8670 5503
Email address
dr.az.seifadini@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2021-12-26, 1400/10/05
Expected recruitment end date
2022-02-09, 1400/11/20
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of the efficacy of SVF cells on the effect of subcision method in the treatment of acne scars; A double blind clinical trial
Public title
Effect of Svf and Subcision in Acne Scar
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Age 20-50 years Moderate and severe acne scars No treatment in 3months ago Conscious consent to participate in the study
Exclusion criteria:
Pregnancy and lactation Malignancy
Age
From 20 years old to 50 years old
Gender
Both
Phase
3
Groups that have been masked
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 10
Randomization (investigator's opinion)
Randomized
Randomization description
Simple randomization and coin tossing methods were used. Performance of alone subcision method was considered as heads and combination therapy was considered as tails and random assignment was performed by tossing a coin.
Blinding (investigator's opinion)
Double blinded
Blinding description
Participants as to which side of the face the Svf injection was given. A dermatologist who evaluates the outcome.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Iran University of Medical Sciences
Street address
NO.9, Bloc 446, Shirdam Town, Babaei Highway
City
Tehran
Province
Tehran
Postal code
1234567890
Approval date
2021-11-26, 1400/09/05
Ethics committee reference number
IR.IUMS.FMD.REC.1399.410

Health conditions studied

1

Description of health condition studied
Acne Scars
ICD-10 code
L70.8
ICD-10 code description
Other acne

Primary outcomes

1

Description
scar mental score
Timepoint
Before and 3 months after the intervention
Method of measurement
Patient Mental Scoring System, Patients are asked to rate the severity of scars seen on their face based on a 0 to 10 scoring comparison (0 without scars and 10 severe scars).

2

Description
scar size
Timepoint
Before and 3 months after the intervention
Method of measurement
Photography with visioface device

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: subcision technique plus SVF
Category
Treatment - Drugs

2

Description
Control group: subcision technique
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Rasool Akram Hospital
Full name of responsible person
‪Masoumeh Roohaninasab
Street address
Hazrat Rasoul Akram Hospital, Niayesh Ave., Sattarkhan Street, Tehran. Iran
City
Tehran
Province
Tehran
Postal code
۱۴۴۵۶۱۳۱۳۱
Phone
+98 21 6435 1000
Email
rohaninasabm@iums.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Najmosadat Atefi
Street address
Iran University of Medical Sciences, next to Milad Tower, Hemmat Highway, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
۱۴۴۹۶۱۴۵۳۵
Phone
+98 21 8670 2213
Email
najmosadatatefi8931@yahoo.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Iran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Azadeh Seiphaddini
Position
Dermatology student
Latest degree
Medical doctor
Other areas of specialty/work
Dermatology
Street address
Iran University of Medical Sciences, next to Milad Tower, Hemmat Highway, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
۱۴۴۹۶۱۴۵۳۵
Phone
+98 21 8670 2213
Email
dr.az.seifadini@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
‪Masoumeh Roohaninasab
Position
Assistant Professor
Latest degree
Specialist
Other areas of specialty/work
Dermatology
Street address
Iran University of Medical Sciences, next to Milad Tower, Hemmat Highway, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
۱۴۴۹۶۱۴۵۳۵
Phone
+98 21 8670 2213
Email
rohaninasab@iums.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Masoumeh Roohaninasab
Position
Assistant Professor
Latest degree
Specialist
Other areas of specialty/work
Dermatology
Street address
Iran University of Medical Sciences, next to Milad Tower, Hemmat Highway, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
۱۴۴۹۶۱۴۵۳۵
Phone
+98 21 8670 2213
Email
rohaninasabm@iums.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Title and more details about the data/document
Data on the main outcome of the study (Oscar recovery rate) will be published in the final report and article.
When the data will become available and for how long
The data will be available one month after the final report.
To whom data/document is available
The data will be available to academic researchers.
Under which criteria data/document could be used
Researchers who intend to meta-analyze About the subject or to define a similar study in a different statistical population can access the data.
From where data/document is obtainable
Azadeh Seifadini: dr.az.seifadini@gmail.com
What processes are involved for a request to access data/document
After sending the request via email, the data will be provided to the applicant in less than a month.
Comments
Loading...